EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 307 filers reported holding EXELIXIS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $329,127 | +27.1% | 15,063 | +21.3% | 0.10% | -24.8% |
Q2 2022 | $259,000 | -31.1% | 12,418 | -39.6% | 0.13% | -41.9% |
Q4 2021 | $376,000 | +41.4% | 20,551 | +89.2% | 0.22% | -66.7% |
Q3 2020 | $266,000 | +0.8% | 10,861 | -2.0% | 0.67% | +347.7% |
Q1 2019 | $264,000 | -47.9% | 11,086 | -57.0% | 0.15% | -44.6% |
Q4 2018 | $507,000 | +177.0% | 25,779 | +150.0% | 0.27% | +236.2% |
Q3 2018 | $183,000 | -45.2% | 10,312 | -25.3% | 0.08% | -15.8% |
Q3 2017 | $334,000 | +30.5% | 13,800 | -19.8% | 0.10% | -29.6% |
Q4 2016 | $256,000 | +70.7% | 17,200 | +47.0% | 0.14% | +53.4% |
Q3 2016 | $150,000 | +85.2% | 11,700 | +12.5% | 0.09% | +125.6% |
Q2 2016 | $81,000 | – | 10,400 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |